The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a Department of ...
16h
FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’ about his conduct
Dr. George Tidmarsh had been placed on leave Friday after Health and Human Services officials were notified of the issues, a ...
The FDA released a new scientific analysis Friday, concluding that fluoride supplements have limited benefits for children’s teeth and may be linked to emerging safety concerns, including gut issues, ...
The dismissal of a lawsuit challenging "climate neutral" labeling claims, a European ban on "meat" names for plant-based foods, a letter urging FDA ...
Citing a ProPublica investigation, lawmakers are calling on the FDA to conduct more drug testing and to alert hospitals and ...
When reports come out about high lead contamination in a popular food item, what should we do? Experts explain how lead gets ...
According to Defense Secretary Pete Hegseth, the strike killed two people, bringing the death toll from all the strikes to at ...
ALLENTOWN, Pa. - People in Pennsylvania could lose their SNAP benefits come November. If the federal government doesn't pass a budget bill and stop the shutdown, many families will be without the ...
The Food and Drug Administration is recalling 16 brands of cinnamon that contain elevated lead levels, which over time can cause neurological problems including learning disabilities in young children ...
During the 6-year period, 199 new indications for solid tumors were approved by the FDA; 138 (69.3%) were also approved by EMA and 124 (62.3%) by ANVISA. Discrepancies between approved labels and the ...
Nearly every Republican senator signed a letter Thursday urging the Food and Drug Administration (FDA) to reverse its decision to approve a “generic” version of the abortion pill mifepristone, which ...
The U.S. Food and Drug Administration is reviewing whether to change the warning label on hormone replacement therapy drugs used to treat menopause symptoms, a move many experts say is long overdue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback